TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
EMM Life Science AB
Closing information (x1000 SEK)
| Closing information | 2024/08 | 2023/08 | 2022/08 |
| Turnover |
27,283
|
27,720 | |
| Financial expenses |
0
|
0 | |
| Earnings before taxes |
4,343
|
2,100 | |
| EBITDA |
2,173
|
2,174 | |
| Total assets |
6,592
|
20,313 | |
| Current assets |
6,503
|
10,992 | |
| Current liabilities |
2,815
|
3,976 | |
| Equity capital |
3,773
|
16,333 | |
| - share capital |
100
|
100 | |
| Employees (average) |
4
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Solvency |
57.2%
|
80.4% | |
| Turnover per employee |
13,642
|
13,860 | |
| Profit as a percentage of turnover |
15.9%
|
7.6% | |
| Return on assets (ROA) |
65.9%
|
10.3% | |
| Current ratio |
231.0%
|
276.5% | |
| Return on equity (ROE) |
115.1%
|
12.9% | |
| Change turnover |
-437
|
8,142 | |
| Change turnover % |
18%
|
-2%
|
42% |
| Chg. No. of employees |
2
|
0
|
0 |
| Chg. No. of employees % |
100%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.